Overview

Recent News

Date	Title and Summary
Toggle Summary Sep 05, 2018	Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference LAKE FOREST, Ill. , Sept. 05, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior management will participate at the 16 th Annual Morgan Stanley Global Healthcare
Toggle Summary Aug 28, 2018	Assertio Therapeutics and Purdue Pharma Settle Patent Infringement Lawsuit Purdue to pay Assertio $62 million in two installments LAKE FOREST, Ill. , Aug. 28, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that the Company has entered into a settlement agreement with Purdue Pharma L.P. with regard to the Company’s patent infringement
Toggle Summary Aug 15, 2018	Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics, Inc. Name Change Reflects Company’s Focus on Neurology, Orphan and Specialty Businesses LAKE FOREST, Ill. , Aug. 15, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, has announced that its corporate name

Filing date	Description	Form	Filing Group	View
Aug 15, 2018	8-K12B	8-K12B	Other	View HTML 0001104659-18-052087.pdf 0001104659-18-052087.rtf 0001104659-18-052087.xls
Mar 29, 2002	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0000912057-02-012655.pdf 0000912057-02-012655.rtf 0000912057-02-012655.xls
Mar 25, 2015	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-15-002712.pdf 0001047469-15-002712.rtf 0001047469-15-002712.xls
Apr 05, 2016	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-16-011902.pdf 0001047469-16-011902.rtf 0001047469-16-011902.xls
Mar 16, 2018	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-18-001778.pdf 0001047469-18-001778.rtf 0001047469-18-001778.xls

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com

Ernst & Young LLP
Palo Alto, CA

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com